Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 22.98 |
| Open | 22.91 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's Range | 22.50 - 23.39 |
| 52 Week Range | 15.58 - 78.58 |
| Volume | |
| Avg. Volume | 425,400 |
| Market Cap | 604.263M |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.04 |
| Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.29 |
- Business Wire
Patients with Uveal Melanoma Tested with DecisionDx®-UM Report Gaining Value from Test Results In Study Conducted In Collaboration with the Melanoma Research Foundation’s CURE OM Initiative
FRIENDSWOOD, Texas, June 23, 2022--Castle announced findings from a study that evaluated uveal melanoma patients’ attitudes toward prognostic testing with DecisionDx-UM®.
- Business Wire
Castle Adds to Evidence Supporting Its Skin Cancer Test Portfolio through Multiple Data Presentations at the SDPA Annual Summer Dermatology Conference 2022
FRIENDSWOOD, Texas, June 22, 2022--Castle shared new data regarding its skin cancer tests at the recent SDPA Annual Summer Dermatology Conference 2022.
- Business Wire
Castle Biosciences Announces Support for OHSU’s War on Melanoma™
FRIENDSWOOD, Texas, June 20, 2022--Castle Biosciences announced a new collaboration with Oregon Health & Science University's War on Melanoma™ public health campaign.
© 2022 Yahoo. All rights reserved.
